Publications by authors named "Pedro Vitor Lemos Cravo"

Medicinal plants have historically been a source of drugs in multiple applications, including the treatment of malaria infections. The Cabo Verde archipelago harbors a rich diversity of native plants, most of which are used for medicinal purposes. The present study investigated the in vitro antiplasmodial activities of four native plants from Cabo Verde (i.

View Article and Find Full Text PDF

Antimalarial drugs with novel modes of action and wide therapeutic potential are needed to pave the way for malaria eradication. Violacein is a natural compound known for its biological activity against cancer cells and several pathogens, including the malaria parasite, (Pf). Herein, using chemical genomic profiling (CGP), we found that violacein affects protein homeostasis.

View Article and Find Full Text PDF
Article Synopsis
  • - Widespread resistance to current antimalarial drugs has sparked the urgent need for new effective treatments, leading researchers to explore drug repositioning as a cost-effective strategy.
  • - A computer-assisted drug repositioning approach identified seven promising drug candidates, with epirubicin being highlighted for further testing due to its strong effectiveness against both drug-sensitive and resistant malaria strains.
  • - Experimental validation revealed that epirubicin not only kills malaria parasites but also blocks their transmission, and further studies aim to understand its mechanism of action, suggesting it could be optimized for use in malaria treatment.
View Article and Find Full Text PDF

Only ~1% of all drug candidates against Neglected Tropical Diseases (NTDs) have reached clinical trials in the last decades, underscoring the need for new, safe and effective treatments. In such context, drug repositioning, which allows finding novel indications for approved drugs whose pharmacokinetic and safety profiles are already known, emerging as a promising strategy for tackling NTDs. Chemogenomics is a direct descendent of the typical drug discovery process that involves the systematic screening of chemical compounds against drug targets in high-throughput screening (HTS) efforts, for the identification of lead compounds.

View Article and Find Full Text PDF

Lagochilascariasis is a parasitic disease caused by a helminth of the order Ascaroidea, genus Lagochilascaris that comprises 6 species, among which only Lagochilascaris minor Leiper, 1909, is implicated in the human form of the disease. It is remarkable that the majority of cases of human lagochilascariasis in the Americas have been reported in Brazil. The natural definitive hosts of this parasite seem to be wild felines and canines.

View Article and Find Full Text PDF

Introduction: The almost exclusive use of only praziquantel for the treatment of schistosomiasis has raised concerns about the possible emergence of drug-resistant schistosomes. Consequently, there is an urgent need for new antischistosomal drugs. The identification of leads and the generation of high quality data are crucial steps in the early stages of schistosome drug discovery projects.

View Article and Find Full Text PDF